Published August 2014 | Version v1
Journal article

Feasibility of high-resolution pituitary MRI at 7.0 tesla

  • 1. University Medical Center Utrecht, Department of Radiology, Heidelberglaan 100, Postbox 85500, Utrecht (Netherlands)
  • 2. University Medical Center Utrecht, Department of Internal Medicine (Section of Endocrinology), Utrecht (Netherlands)
  • 3. Philips Healthcare, Best (Netherlands)

Description

Since the pituitary gland measures 3-8 mm, imaging with the highest possible spatial resolution is important for the detection of even smaller lesions such as those seen in Cushing's disease. In the current feasibility study, we tested a multi-sequence MRI protocol to visualize the pituitary gland in high resolution at 7.0 Tesla (7.0 T). Ten healthy volunteers were examined with a 7.0 T pituitary gland protocol. The protocol consisted of a T1-weighted magnetization-prepared inversion recovery (MPIR) turbo spin-echo (TSE) sequence and a T2-weighted TSE sequence. Additionally, this protocol was tested in five patients with clinical and biochemical suspicion of a microadenoma. The dedicated protocol was successful in visualizing normal pituitary anatomy. At 7.0 T compared to 1.5 T, four times as many slices covered the pituitary gland in sagittal and coronal direction. In three patients, a lesion was diagnosed at 7.0 T, and was confirmed by histopathology to be a microadenoma. Head-to-head comparisons of 7.0 T with 1.5 T and 3.0 T are needed with larger samples of patients and with imaging times feasible for clinical settings. However, the current study suggests that high-resolution 7.0 T MRI of the pituitary gland may provide new perspectives when used as a second-line diagnostic examination in the specific context of Cushing's disease. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-014-3230-x

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
24
Journal Issue
8
Journal Page Range
p. 2005-2011
ISSN
0938-7994
CODEN
EURAE3